ATE451097T1 - Valsartanformulierungen - Google Patents

Valsartanformulierungen

Info

Publication number
ATE451097T1
ATE451097T1 AT08104077T AT08104077T ATE451097T1 AT E451097 T1 ATE451097 T1 AT E451097T1 AT 08104077 T AT08104077 T AT 08104077T AT 08104077 T AT08104077 T AT 08104077T AT E451097 T1 ATE451097 T1 AT E451097T1
Authority
AT
Austria
Prior art keywords
valsartan
formulations
valsartan formulations
active agent
microcrystalline cellulose
Prior art date
Application number
AT08104077T
Other languages
English (en)
Inventor
Uemit Cifter
Ali Tuerkyilmaz
Hasan Ali Turp
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38982518&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE451097(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanovel Ilac Sanayi Ve Ticaret filed Critical Sanovel Ilac Sanayi Ve Ticaret
Application granted granted Critical
Publication of ATE451097T1 publication Critical patent/ATE451097T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT08104077T 2007-05-24 2008-05-23 Valsartanformulierungen ATE451097T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2007/03568A TR200703568A1 (tr) 2007-05-24 2007-05-24 Valsartan formülasyonları

Publications (1)

Publication Number Publication Date
ATE451097T1 true ATE451097T1 (de) 2009-12-15

Family

ID=38982518

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08104077T ATE451097T1 (de) 2007-05-24 2008-05-23 Valsartanformulierungen

Country Status (12)

Country Link
US (1) US20080293789A1 (de)
EP (1) EP1994926B9 (de)
AT (1) ATE451097T1 (de)
CY (1) CY1109865T1 (de)
DE (1) DE602008000367D1 (de)
DK (1) DK1994926T3 (de)
ES (1) ES2337848T3 (de)
HR (1) HRP20100120T1 (de)
PL (1) PL1994926T3 (de)
PT (1) PT1994926E (de)
SI (1) SI1994926T1 (de)
TR (1) TR200703568A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010104485A2 (en) * 2009-03-11 2010-09-16 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Valsartan formulations
TR201005419A2 (tr) * 2010-07-05 2012-01-23 B�Lg�� Mahmut Valsartan içeren farmasötik bileşim.
EP2990029A1 (de) * 2014-08-29 2016-03-02 Sandoz Ag Pharmazeutische Zusammensetzungen mit Canagliflozin
CN105769788A (zh) * 2016-03-11 2016-07-20 江苏中邦制药有限公司 一种缬沙坦片剂及制备方法
CN105816419A (zh) * 2016-05-26 2016-08-03 陈欣怡 一种包含缬沙坦的药物组合物
CN112807286A (zh) * 2021-01-20 2021-05-18 海南皇隆制药股份有限公司 一种缬沙坦分散片制备方法和缬沙坦分散片
CN112826806A (zh) * 2021-01-20 2021-05-25 海南皇隆制药股份有限公司 一种缬沙坦片制备方法和缬沙坦片
TW202541805A (zh) * 2023-12-28 2025-11-01 大陸商和記黃埔醫藥（上海）有限公司 一種醫藥組成物及其應用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK117793A3 (en) 1991-04-29 1994-05-11 Merck & Co Inc Optimized tablet formulation
DE4408497A1 (de) 1994-03-14 1995-09-21 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
BR9507086A (pt) 1994-03-17 1997-09-16 Ciba Geigy Ag Tratamento de nefroterapia diabética com valsartan
TW442301B (en) 1995-06-07 2001-06-23 Sanofi Synthelabo Pharmaceutical compositions containing irbesartan
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
ES2373556T3 (es) 1998-12-23 2012-02-06 Novartis Ag Comprimidos de valsartán.
US20020132839A1 (en) * 2000-06-22 2002-09-19 Ganter Sabina Maria Tablet formulations comprising valsartan
US9173847B2 (en) * 2003-10-10 2015-11-03 Veloxis Pharmaceuticals A/S Tablet comprising a fibrate
WO2005041941A2 (en) 2003-11-03 2005-05-12 Zentiva, A.S. Valsartan containing formulation
AU2005318365B2 (en) * 2004-12-24 2011-02-03 Krka, D.D., Novo Mesto Solid pharmaceutical composition comprising valsartan
EP1906936A2 (de) * 2005-05-18 2008-04-09 Combino Pharm, S.L. Formulierungen mit losartan und/oder dessen salzen
GT200600371A (es) * 2005-08-17 2007-03-21 Formas de dosis sólidas de valsartan y amlodipina y método para hacer las mismas
WO2007049292A1 (en) * 2005-10-27 2007-05-03 Lupin Limited Pharmaceutical formulation of losartan
WO2007049291A1 (en) * 2005-10-27 2007-05-03 Lupin Limited Novel solid dosage forms of valsartan and rochlorothiazide
US20080227836A1 (en) * 2005-10-31 2008-09-18 Lupin Ltd Stable Solid Oral Dosage Forms of Valsartan

Also Published As

Publication number Publication date
EP1994926B9 (de) 2010-05-19
SI1994926T1 (sl) 2010-04-30
EP1994926B1 (de) 2009-12-09
PL1994926T3 (pl) 2010-05-31
CY1109865T1 (el) 2014-09-10
TR200703568A1 (tr) 2008-07-21
PT1994926E (pt) 2010-03-16
ES2337848T3 (es) 2010-04-29
EP1994926A1 (de) 2008-11-26
DK1994926T3 (da) 2010-04-26
HRP20100120T1 (hr) 2010-04-30
US20080293789A1 (en) 2008-11-27
DE602008000367D1 (de) 2010-01-21

Similar Documents

Publication Publication Date Title
CY1109865T1 (el) Συνθεσεις βαλσαρτανης
NO20083630L (no) Nye pyridinderivater
BRPI0820997A2 (pt) Comprimidos de desintegração oral compreendendo difenidramina.
NO20091395L (no) Nye tiofenderivater
NO20082793L (no) Nye tiofenderivater
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
MY153921A (en) Aminopyrazole derivatives
MY154909A (en) Novel thiophene derivatives
DK3984528T3 (da) Farmaceutiske sammensætninger, som omfatter nilotinib
NO20075298L (no) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
NO20090295L (no) Substituerte heteroarylderivater
TNSN08326A1 (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
MX342440B (es) Derivados fluorados de aminotriazol.
MX350447B (es) Composicion farmaceutica de disolucion rapida.
SI2242740T1 (sl) SF5-derivati kot PAR1 inhibitorji, njihova priprava in uporaba kot zdravila
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
UA107671C2 (en) N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
NI201100227A (es) Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amlodipina, su preparación y su aplicación terapéutica.
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
WO2011037976A3 (en) Pramipexole pharmaceutical formulations
MX2009007764A (es) Formulacion de nevirapina de liberacion prolongada.
MA32461B1 (fr) Dronedarone pour la prevention de cardioversion
ATE533477T1 (de) Pharmazeutische zusammensetzungen enthaltend irbesartan
WO2010104485A3 (en) Valsartan formulations
EA200801678A1 (ru) Применение производных триазина для производства лекарственного средства, обладающего заживляющим или ангиогенным эффектом

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1994926

Country of ref document: EP